OBJECTIVE This article reviews the neurologic syndromes associated with substance use and suggests an approach for identifying and managing substance use disorders. LATEST DEVELOPMENTS Substance use and overdose mortality, largely associated with fentanyl, rose sharply during the COVID-19 pandemic. Although recent data indicate modest decreases, current rates of overdose remain higher than before the pandemic. A wide variety of opioid-related toxic encephalopathies have been identified recently. Many novel psychoactive substances are unregulated and easily obtained online or in stores; several have been associated with seizures and other neurologic complications. The use of cannabis and hallucinogens is rising as more states legalize or decriminalize their use, and some studies suggest an independent association between cannabis use and ischemic stroke. ESSENTIAL POINTS Neurologists often encounter severe complications of substance use and have an opportunity to guide patients with substance use disorders toward treatment.
ABSTRACT
PUBLICATION RECORD
- Publication year
2026
- Venue
Continuum
- Publication date
2026-02-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1